01 January 1999
Hemispheric activation in paranoid schisophrenia and unipolar depression measured by electronystagmography of conjugate lateral eye movement
Alina Borowska, Janusz K. Rybakowski, Aleksander AraszkiewiczMed Sci Monit 1999; 5(1): CR84-88 :: ID: 505257
Abstract
Conjugate lateral eye movements (CLEM) measurements elicited in response to different stimuli (e.g. questions of cognitive or emotional content) have been used as an index of activation of contralateral hemispheres. In our study, hemispheric activation measured by electronystagmographic method of CLEM determination in response to cognitive emotional and spatial questions was assessed in ten paranoid schizophrenics and ten unipolar depressed female patients both during acute episode and on improvement after pharmacological treatment. The results were compared with the control group of ten healthy women. During acute episode of the illness, schizophrenic patients, compared with controls, exhibited excessive activation of left hemisphere in response to emotional and spatial stimuli. On improvement, there was a significant decrease of patients left hemisphere activation and the increase of right hemisphere activation. In depressed patients during acute episode, the advantage of right hemisphere activation over the left hemisphere in response to cognitive stimuli was observed. These changes persisted into remission period. The results point to specific alterations of hemispheric activation in schizophrenia and depression during acute episode and also to different changes of such activation after clinical improvement and/or pharmacological treatment.
key words: hemispheric activation • conjugate lateral eye movements • schizophrenia • depression • acute episode • remission • pharmacological treatment
Keywords: pharmacological treatment, remission, acute episode, Depression, Schizophrenia
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952